Aquatic Capital Management’s Regencell Bioscience RGC Stock Holding History
Bought
Maintained
Sold
Other funds holding RGC
Aquatic Capital Management's RGC Position: Q3 2026 in Review
Aquatic Capital Management sold out of Regencell Bioscience (RGC) in Q3 2026, closing a stake of 2,058 shares — an estimated $12.5K sold.
Aquatic Capital Management first reported a position in RGC in Q2 2026 and held it in 1 quarter. The position peaked at $12.5K in Q2 2026. 31 funds tracked by Wall St. Rank hold RGC as of Q3 2026.
- Aquatic Capital Management reported no remaining Regencell Bioscience position as of Q3 2026 after selling out during the quarter.
- Aquatic Capital Management sold 2,058 Regencell Bioscience shares in Q3 2026, an estimated $12.5K.
- Aquatic Capital Management first reported a position in Regencell Bioscience in Q2 2026 and held it in 1 quarter.
- Aquatic Capital Management's Regencell Bioscience position peaked at $12.5K in Q2 2026.
- 31 funds tracked by Wall St. Rank held Regencell Bioscience as of Q3 2026.
Based on Aquatic Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.